YA4-20485-99165
1 vaccination
3 coded responses
4 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Survey response — day 0, dose 1MedDRA: Morning sickness, Nausea — Feeling: Good · Site: Pain · NauseaFree text: Nausea is from morning sicknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
-
2021-04-02
Survey response — days 1–6 daily, dose 1MedDRA: Morning sickness — Feeling: Fair · Site: Pain · NauseaFree text: Morning sicknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Morning sickness — Feeling: Good · NauseaFree text: Morning sicknessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): Nausea is from morning sickness
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Morning sickness
Systemic reaction (other): Morning sickness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Morning sickness | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release